Vaginal
Ethinyloestradiol + Etonogestrel
NuvaRing
- Mechanism of Action
- Contains an oestrogen and a progesterone, which inhibit follicular development, prevent ovulation and thicken cervical mucus resulting in reduced sperm penetration.
- Pharmacology
- Releases ostrogen and progestin directly into the vagina.
- Useful for patients who are poorly compliant with oral therapy, and for patients with malabsorption.
Clinical Use
- Indication
- Contraception.
- Contraindications
- Pregnancy
- Past DVT / PE
- Ischaemic heart disease
- Past stroke / TIA
- Liver failure
- Breast / uterine / cervical / ovarian cancer
- Migraine with aura
- Adverse Effects
- Nausea / abdominal pain
- Weight gain
- Headache
- Depression
- Breast pain
Want more info like this?
- Your electronic clinical medicine handbook
- Guides to help pass your exams
- Tools every medical student needs
- Quick diagrams to have the answers, fast
- Quizzes to test your knowledge
Explore